Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Carney-Stratakis syndrome (CSS) is a rare, autosomal dominant condition characterized by the dyad of gastrointestinal stromal tumors (GISTs) and paragangliomas (PGLs), arising from germline inactivating variants in succinate dehydrogenase subunit genes. SDHC, encoding a membrane‐anchoring subunit of mitochondrial complex II, has been implicated in CSS through multiple independent reports demonstrating loss-of-function variants in affected individuals.
Three unrelated CSS probands harboring distinct germline SDHC loss-of-function variants have been documented: a canonical splice-site mutation c.405+1G>A in a large family with multiple PGLs and GISTs (PMID:38021081), a nonsense variant c.43C>T (p.Arg15Ter) in a 45-year-old woman with bilateral paragangliomas and multifocal gastric GIST (PMID:32944103), and a novel SDHC frameshift resulting from exon 3 deletion in a pediatric patient with multifocal GIST (PMID:31883676).
Segregation analysis in one two-generation family confirmed cosegregation of the c.405+1G>A SDHC variant with PGL and GIST in an affected father and daughter (1 additional relative) (PMID:38021081).
The SDHC variant spectrum in CSS includes canonical splice-site mutations (c.405+1G>A) and early truncating alleles (c.43C>T (p.Arg15Ter)), all predicted to abolish protein function. No recurrent or founder SDHC alleles have been reported to date.
Functional studies demonstrate concordant complex II deficiency: SDHC-mutant tumors show absence of SDHB immunostaining, reflecting secondary SDHB destabilization (PMID:21173220), and enzymatic assays confirm diminished succinate dehydrogenase activity in SDHC-deficient GIST samples. Yeast complementation models of SDHC orthologs further validate the pathogenicity of analogous missense and splice variants (PMID:17636259).
Integration of genetic and functional data supports a ClinGen Moderate clinical validity classification for SDHC in CSS. Germline testing for SDHC variants is recommended in patients presenting with concurrent PGL and GIST, enabling early surveillance for associated tumors and facilitating cascade testing in at-risk relatives.
Key Take-home: Germline loss-of-function variants in SDHC underlie Carney-Stratakis syndrome through haploinsufficiency of mitochondrial complex II; genetic diagnosis enables targeted surveillance and family counseling.
Gene–Disease AssociationModerate3 unrelated probands [PMID:32944103; PMID:31883676; PMID:38021081], segregation in a two-generation family, concordant SDHB IHC loss Genetic EvidenceModerate3 distinct germline SDHC loss-of-function variants in unrelated CSS probands; one two-generation segregation Functional EvidenceModerateSDHB immunostaining loss and reduced complex II activity in SDHC-mutant tumors |